We're happy to announce the #ArteraAI Prostate Test is the First-and-Only Predictive Test for Therapy Personalization in the 2024 @NCCN Guidelines for #ProstateCancer underscoring the importance of incorporating innovative tools for personalized treatment: https://t.co/g6TTSER7Ma

We’re heading to Chicago for #LUGPA2025 this November! Excited to connect with independent urology leaders and share how Artera is supporting smarter, faster prostate cancer decisions with AI. #ArteraAI #Urology #ProstateCancer #PrecisionMedicine @LUGPA

Prostate cancer affects everyone differently. AI can help doctors spot patterns in biopsy images to guide decisions, like whether short-term ADT with radiation may help. Because cancer is personal, therapy should be too. Learn more in this summary of our predictive validation:

New from @UrologyTimes: A recent validation study shows #MMAI model performs consistently in Asian patients with localized prostate cancer. Read the article: https://t.co/PRQsyEmvEV #ArteraAI #ProstateCancer #HealthEquity

That’s a wrap on #ASTRO2025! Great connecting in SF and sharing how Artera’s AI platform is helping radiation oncologists make faster, more personalized decisions in prostate cancer care. #ArteraAI #RadiationOncology #AIinHealthcare #PrecisionMedicine

NIH research shows prostate and breast cancers share biomarkers like BRCA2 and PTEN: https://t.co/YG4xaLIgAN At Artera, insights from our prostate cancer work are also guiding research in breast cancer—helping move toward more precise, personalized care. #BCAM

We’re heading to Point Clear, AL for the Alabama Urology Network 2025 Meeting—Oct 24–26! Looking forward to connecting and sharing how Artera is helping personalize prostate cancer care through AI. #ArteraAI #Urology #ProstateCancer #PrecisionMedicine

We’re heading to San Juan for the 76th Puerto Rico Urological Association Meeting this October! Looking forward to connecting and sharing how Artera is helping personalize prostate cancer care with AI. #ArteraAI #PRUA76 #Urology #ProstateCancer #PrecisionMedicine

Four years ago, a meeting between Andre Esteva and UCSF researcher Felix Feng, facilitated by Marc Benioff, led to Artera. Today, the ArteraAI Prostate Test is FDA-authorized and helping clinicians guide prostate cancer care, via @SFBusinessTimes: https://t.co/u7K3tM3hT3

We’re headed to Las Vegas for #SPCS2025! Join us as we explore the latest in imaging, diagnostics, & treatment of prostate cancer. Looking forward to connecting and sharing how Artera is helping personalize care. #ArteraAI #ProstateCancer #Urology #PrecisionMedicine

The #ArteraAI Prostate is the first AI-powered digital pathology tool with FDA De Novo authorization for #prostatecancer. Huge thanks to @MSN and Dr. Adam Cole for highlighting how this helps patients get the right treatment faster & smarter. 📖

This past weekend, we proudly teamed up with @ZEROCancer to host our second annual Virtual Walk, supporting #prostatecancer awareness month. A heartfelt thank you to all the participants for inspiring us with their dedication and performance!

We’re excited to be featured in @MobiHealthNews for the recent FDA DeNovo authorization of ArteraAI Prostate, the first and only AI-powered software designed to help clinicians make risk-based decisions for men with non-metastatic prostate cancer: https://t.co/qtXUxPSf17

How does Artera’s MMAI architecture work? Our multimodal AI model analyzes both a patient’s biopsy image and their clinical data to predict therapeutic benefit—something conventional tools can’t do alone. #BreastCancerAwarenessMonth

At #ASTRO25, Dr. Melvin L.K. Chua (@DrMLChua) shared data confirming the ArteraAI Prostate Test’s performance in an Asian cohort. As covered in @UrologyTimes, this adds to prior validation across Western and African American patients: https://t.co/PRQsyEmvEV

That’s a wrap on #DDxSummit2025! Grateful to have our CCO Amanda Lowe share how Artera is bringing AI-powered digital pathology into real-world clinical practice. Thanks to all who joined the conversation in Utah! #ArteraAI #DigitalPathology #AIinHealthcare #PrecisionMedicine

Exciting news - Artera will present four abstracts at #ASTRO25, including validation of ArteraAI Prostate in an Asian cohort, a new head and neck cancer biomarker, and data showing how MMAI biomarkers complement genomic classifiers: https://t.co/L1SsSZE5As

As a #bayarea company, we're excited that #ASTRO2025 is happening here in SF. Be sure to come check us out at booth #3205, right outside Exhibit Hall B, over the next few days to learn more about how the #ArteraAI Prostate Test is transforming #prostatecancer care.

That’s a wrap on #IUP2025 in New Mexico! Great connecting with urology leaders and sharing how Artera’s AI platform supports more personalized prostate cancer care. Thanks to everyone who stopped by our booth! 👋 #ArteraAI #Urology #ProstateCancer #PrecisionMedicine

Thanks to Dr. Cole for highlighting how Artera's AI tools can help reduce anxiety by speeding up treatment decisions with 1–2 day turnaround times. @cure_today https://t.co/9HnW8DoGK0 #ArteraAI #ProstateCancer #PrecisionMedicine

Join us at the DDx Summit, a unique event dedicated to moving the needle on #digitalpathology solutions. We'll be there from September 28-30 in Park City, UT. See you there! #ArteraAI